Aligos Therapeutics, Inc. (ALGS) vs NextCure, Inc. (NXTC)
- Aligos Therapeutics, Inc. ALGS 4.86 −9.83%
- NextCure, Inc. NXTC 6.24 −9.30%
Aligos Therapeutics, Inc. and NextCure, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and NextCure, Inc. are of similar size ($33.7M and $31.5M). NextCure, Inc. has the higher net margin (0.00% vs −241.0%) and the higher return on invested capital (0.00% vs −3,379.3%). Across the 15 metrics below, NextCure, Inc. leads on 10 and Aligos Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ALGS | NXTC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (250.63%) | 0.00% | 0.00% |
| Net margin | (241.01%) | 0.00% | 0.00% |
| Free cash flow margin | (299.90%) | 0.00% | 0.00% |
| Return on equity | (113.59%) | (195.22%) | (56.36%) |
| Return on assets | (75.57%) | (121.60%) | (48.04%) |
| Return on invested capital | (3,379.28%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack